Bulletin
Investor Alert

Horizon Therapeutics PLC

NAS: HZNP

GO
/marketstate/country/us

After Hours

 --Quotes are delayed by 20 min

May 20, 2022, 5:20 p.m.

/zigman2/quotes/206690250/composite

$

90.35

Change

0.00 0.00%

Volume

Volume 231,939

Quotes are delayed by 20 min

/zigman2/quotes/206690250/composite

Previous close

$ 89.34

$ 90.35

Change

+1.01 +1.13%

Day low

Day high

$87.88

$90.87

Open

52 week low

52 week high

$82.51

$120.54

Open

Gino Santini

Gino Santini is on the board of ImClone LLC and 7 other companies. Mr. Santini previously occupied the position of Senior VP-Business Development & Strategy at Eli Lilly & Co. and General Manager for Eli Lilly y CIA de México SA de CV (a subsidiary of Eli Lilly & Co.), Chairman for AMAG Pharmaceuticals, Inc., Chairman at National Pharmaceutical Council and Chairman at Noble of Indiana.

He received an undergraduate degree from Alma Mater Studiorum - Università di Bologna and an MBA from the University of Rochester Simon Business School.

Transactions

Date Shares Transaction Value
04/29/2022 1,658   Derivative/Non-derivative trans. at $98.56 per share. 163,413
04/29/2022 4,223   Derivative/Non-derivative trans. at $0 per share. 0
04/30/2021 4,357   Derivative/Non-derivative trans. at $94.62 per share. 412,260
04/30/2021 11,098   Derivative/Non-derivative trans. at $0 per share. 0
03/01/2021 12,000   Disposition at $91.47 per share. 1,097,640
08/03/2020 20,000   Derivative/Non-derivative trans. at $2.37 per share. 47,400
08/03/2020 5,265   Derivative/Non-derivative trans. at $3.95 per share. 20,796
08/03/2020 10,530   Derivative/Non-derivative trans. at $3.33 per share. 35,064
05/02/2020 6,041   Derivative/Non-derivative trans. at $35.62 per share. 215,181
05/02/2020 15,390   Derivative/Non-derivative trans. at $0 per share. 0
05/03/2019 6,014   Derivative/Non-derivative trans. at $26.54 per share. 159,612
05/03/2019 15,320   Derivative/Non-derivative trans. at $0 per share. 0
05/03/2018 5,517   Derivative/Non-derivative trans. at $13.87 per share. 76,521
05/03/2018 14,054   Derivative/Non-derivative trans. at $0 per share. 0

Officers and Executives

Mr. Timothy P. Walbert
Chairman, President & Chief Executive Officer
Mr. Aaron L. Cox
Chief Financial Officer & Executive Vice President
Dr. Karin Rosen
Chief Scientific Officer
Dr. Elizabeth H. Z. Thompson
Executive Vice President-Research & Development
Dr. Jeffrey W. Sherman
Chief Medical Officer & Executive Vice President
Mr. Michael A. DesJardin
Executive VP-Technical Operations & Quality
Dr. Jeffrey D. Kent
Executive VP-Medical Affairs & Outcomes Research
Mr. Andy Pasternak
Chief Strategy Officer & Executive Vice President
Ms. Holly Copeland
Senior Director-Corporate Social Responsibility
Ms. Marilyn Vetter
Group Vice President-Market Access
Mr. Vikram Karnani
President-International & Executive Vice President
Mr. Miles W. McHugh
Chief Accounting Officer & Senior Vice President
Ms. Tina Ventura
Chief Investor Relations Officer & Senior VP
Ms. Jane Gonnerman
Chief of Staff & Group Vice President-Development
Ms. Irina P. Konstantinovsky
EVP, Chief Human Resources & Diversity Officer
Mr. David Caraher
Secretary
Mr. Sean M. Clayton
Executive Vice President & General Counsel
Dr. Susan Mahony
Independent Director
Mr. Michael G. Grey
Lead Independent Director
Dr. Jeff Himawan
Independent Director
Mr. William Francis Daniel
Independent Director
Ms. Pascale Witz
Independent Director
Dr. James Samuel Shannon
Independent Director
Mr. H. Thomas Watkins
Independent Director
Mr. Gino Santini
Independent Director
Link to MarketWatch's Slice.